Novartis, CH0012005267

Novartis stock ends the day at USD 141.43 after the close

Published on 09/22/2026 at 23:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Novartis stock finished at USD 141.43 on the NYSE. The ADR opened at USD 141.28, while pharmaceutical shares faced renewed pipeline concerns.

Forscherin in weißem Kittel pipettiert in Reagenzglas im sterilen Pharmalabor
Novartis AG CH0012005267 – Forscherin pipettiert präzise in steriler Pharmalaborumgebung mit Reagenzgläsern, Illustration mit AI erstellt.

Novartis stock closed at USD 141.43 on the NYSE on September 22, 2026, a regular-session value of 0.00 percent from the prior close. The ADR opened at USD 141.28, leaving the closing price USD 0.15 above the opening level.

September 22, 2026 session profile

Novartis AG (ISIN CH0012005267, NYSE: NVS) traded against a pharmaceutical backdrop shaped by pipeline setbacks. As Reuters reported, more than USD 40 billion had been wiped from AstraZeneca and Novartis in recent weeks as investors questioned drugmakers' dealmaking strategies.

Novartis therefore ended USD 1.49 below its reported 52-week high of USD 142.92 and USD 19.86 above its 52-week low of USD 121.57. On the home market, the shares had closed 0.22 percent higher on SIX at 11:35 a.m. ET, while the U.S. ADR finished at USD 141.43.

After the bell today

Novartis had no company-specific event scheduled after the U.S. close in the cited earnings calendar. The next trading session is September 23, 2026, when market participants will continue to assess pharmaceutical pipeline news and analyst actions affecting the sector.

Disclaimer...

en | CH0012005267 | NOVARTIS | boerse | 70160056 | bgmi